Explore our resources by research/diagnostic specialty or content type

ALPCO specialists are leveraging their extensive expertise to create a growing collection of resources for your research and testing. Find resources that benefit your work using the handy filters.

Flash Chemiluminescence

KleeYa Platform Overview
April 12, 2023

KleeYa Platform Overview

Experience the sensitivity and accuracy of ALPCO flash chemiluminescence assays combined with the sample-to-answer, random access capability of the KleeYa® platform.

KleeYa Specifications
April 12, 2023

KleeYa Specifications

Combine the sensitivity and accuracy of ALPCO’s flash chemiluminescence assays with the efficiency of the KleeYa® analysis platform.

Understanding Exocrine Pancreatic Insufficiency
May 19, 2022

Understanding Exocrine Pancreatic Insufficiency

Pancreatic Elastase (PE) Testing for Determination of Exocrine Pancreatic Insufficiency (EPI) Advantages of ALPCO PE Testing for Determination of EPI • No interference from PERT • Single sample collection without dietary restriction • Detection of both CELA3A and CELA3B isoforms • Compatibility with current clinical cut-offs • FDA Class I Device. For In Vitro Diagnostic Use. • Accura...
ALPCO’s Calprotectin Validation Assistance Program
April 22, 2020

ALPCO’s Calprotectin Validation Assistance Program

Whether your clinical laboratory is transitioning over to the ALPCO Calprotectin Chemiluminescence ELISA from another calprotectin assay or starting to run the test in-house for the first time, validation is the most crucial step in the assay implementation process. We understand that validating a new ELISA can be a constant balancing act of keeping current laboratory operations functioning whi...
An Accurate Solution to the Challenges with Measuring GLP-1
July 31, 2018

An Accurate Solution to the Challenges with Measuring GLP-1

Glucagon-like peptide-1 (GLP-1) is a gut hormone which plays an essential role in insulin secretion and glucose homeostasis1. While GLP-1 has become central to many metabolic disease research programs, various GLP-1 ELISA kits currently available on the market have been failing to meet the needs of researchers1-5. Therefore, measuring total and active levels of GLP-1 is difficult for many labs2...